Astellas has an extensive background in urology, making the company in this field of medicine a world leader. This is due to an excellent portfolio of medications in this area.

In Astellas, we focus our resources and experience in areas where medical needs are still not met. Astellas leads the development of innovative treatments for Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Through our commitment to ongoing research, we are working to identify and develop innovative solutions to current challenges in urology and offer patients hope for a better future.

EN_PIL Betmiga | EN_PIL Omnic Tocas | EN_PIL_Vesicare tabs | EN_PIL_Vesomni | EN_Vesicare OS

Learn more about our therapeutic areas: